Imaging of acute stroke

Applied Radiology

Volumn 34, Issue 2, 2005, Pages 10-19

  Choksi, Vaishali ^a   Quint, Douglas J ^a   Maly Sundgren, Pia ^a   Hoeffner, Ellen ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ARTICLE; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN INFECTION; BRAIN TUMOR; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; ENDARTERECTOMY; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PERFUSION WEIGHTED IMAGING; STROKE;

EID: 14644425929     PISSN: 01609963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Head Disease and Stroke Statistics - 2003 Update. American Heart Association, Dallas, Texas, 2003.
2. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
3. Del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998; 29:4-11.
4. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282: 2003-2011.
5. Patel SC, Levine SR, Tilley BC, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001;286:2830-2838.
6. Tomsick TA, Brott TG, Chambers AA, et al. Hyperdense middle cerebral artery sign on CT: Efficacy in detecting middle cerebral artery thrombosis. AJNR Am J Neuroradiol. 1990;11:473-477.
7. Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultra-early thrombolytic therapy. AJNR Am J Neuroradiol. 1996;17:79-85.
8. Provenzale JM, Jahan R, Naidich TP, et al. Assessment of the patient with hyperacute stroke: Imaging and therapy. Radiology. 2003;229:347-359.
9. Tomandl BF, Hastreiter P, Iserhardt-Bauer S, et al. Standardized evaluation of CT angiography with remote generation of 3D video sequences for the detection of intracranial aneurysms. RadioGraphics. 2003;23:e12.
10. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
11. Von Kummer R, Bourquain H, Bastianello S, et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology. 2001;219:95-100.
12. Moseley ME, Butts K. Diffusion and perfusion. In: Stark DD, Bradley WG, eds. Magnetic Resonance Imaging. 3rd ed. St. Louis, MO: Mosby-Year Book; 1999:1515-1538.
13. DeLano MC, Cao Y. High b-value diffusion imaging. Neuroimag Clin North Am Imaging. 2002;12:21-34.
14. Kidwell CS, Saver JL, Mattiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000;47:462-469.
15. Wang PY-K, Barker PB, Wityk RJ, et al. Diffusion-negative stroke: A report of two cases. AJNR Am J Neuroradiol. 1999;20:1876-1880.
16. Kaufmann AM, Firlik AD, Fukui MB, et al. Ischemic core and penumbra in human stroke. Stroke. 1999; 30:93-99.
17. Rohl L, Ostergaard L, Simonsen CZ, et al. Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke. 2001;32:1140-1146.
18. Simonsen CZ, Rohl L, Vestergaard-Poulsen P, et al. Final infarct size after acute stroke: Prediction with flow heterogeneity. Radiology. 2002;225:269-275.
19. Karonen JO, Liu Y, Vanninen RL, et al. Combined perfusion- and diffusion-weighted MR imaging in acute ischemic stroke during the 1st week: A longitudinal study. Radiology. 2000;217:886-894.
20. Sunshine JL, Bambakidis N, Tarr RW, et al. Benefits of perfusion MR imaging relative to diffusion MR imaging in the diagnosis and treatment of hyperacute stroke. AJNR Am J Neuroradiol. 2001;22:915-921.
21. Hatazawa J, Shimosegawa E, Toyoshima H, et al. Cerebral blood volume in acute brain infarction: A combined study with dynamic susceptibility contrast MRI and 99mTc-HMPAO-SPECT. Stroke. 1999; 30: 800-806.
22. Neumann-Haefelin T, Wiffsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI: The DWI/PWI mismatch region in acute stroke. Stroke. 1999;30:1591-1597.
23. Albers GW. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Stroke. 1999;30:2230-2237.
24. Konig M, Klotz E, Heuser L. Diagnosis of cerebral infarction using perfusion CT: State of the Art. Electro-media. 2000;68:9-10.
25. Radaideh M, Devine C, Schomer D, et al. Correlating the basic chronological pathophysiologic neuronal changes in response to ischemia with multisequence MRI imaging. Neurographics. 2003;2:1. Online journal available at www.neurographics.org/2/2/1/. Accessed June 2004.
26. Chuang YM, Chao AC, Teng MM, et al. Use of CT angiography in patient selection for thrombolytic therapy. Am J Emerg Med. 2003;21:167-172.